Locoregional recurrence · patients with localised primary cutaneous melanoma
SLNB may leads to lower rate of pathologically confirmed locoregional recurrence following… compared with observation (low certainty).
1 finding from 1 review
Rate of development of distant metastases following SLNB and curative CLND First pathologically confirmed distant metastasis · patients with localised primary cutaneous melanoma
SLNB may leads to higher rate of development of distant metastases following SLNB and… compared with observation (low certainty).
1 finding from 1 review
Overall Survival Intention‐to‐treat Death from any cause during the study · patients with localised primary cutaneous melanoma
SLNB showed no clear difference in overall Survival Intention‐to‐treat Death from any cause during the… compared with observation (low certainty).
1 finding from 1 review
Surgical Morbidity (Within 30 d) Related to the Regional Nodal Basin in Patients Assigned to the 2 Treatment Arms of MSLT‐I Any complication in the dissected basin, regional or systemic related to the surgical treatment in the regional nodal basin · patients with localised primary cutaneous melanoma
SLNB may leads to higher surgical Morbidity (Within 30 d) Related to the Regional Nodal Basin… compared with observation (low certainty).
1 finding from 1 review
Surgical Morbidity (Within 30 d) Related to Wide Excision of the Primary Site in Patients Assigned to the 2 Treatment Arms of MSLT‐I Any Surgical Complication related to the wide excision site · patients with localised primary cutaneous melanoma
SLNB showed no clear difference in surgical Morbidity (Within 30 d) Related to Wide Excision of the… compared with observation (low certainty).
1 finding from 1 review
Disease‐specific Survival Death from melanoma · patients with localised primary cutaneous melanoma
SLNB showed no clear difference in disease‐specific Survival Death from melanoma compared with observation (low certainty).
1 finding from 1 review
Disease‐free Survival First pathologically confirmed recurrence · patients with localised primary cutaneous melanoma
SLNB may leads to lower disease‐free Survival First pathologically confirmed recurrence compared with observation (low certainty).
1 finding from 1 review